Oxymatrine Glucose Injection

Product description:The main ingredients of this product and its chemical name is oxymatrine.It is colorless or almost colorless clear liquid used for chronic hepatitis B treatment
Molecular formula: C15H24N2O2 · H2O 
Molecular Weight: 282.38 
Specifications:100ml: matrine 0.6g, glucose 5.0g. 
Dosage:Intravenous infusion. Once a day, each 0.6g (1 bottle), February for a course, or as directed. 
Adverse reactions:This product has good patient tolerability, low incidence of adverse reactions. Common adverse reactions are dizziness, vomiting, mouth pain, diarrhea, abdominal discomfort or pain, occasionally rash, chest tightness, fever, symptoms generally resolved spontaneously. Individual patients may be the injection site redness. 
Taboo:Allergic to the chemicals were banned. 
Notes:under the guidance of doctors to the FDA;severe renal dysfunction is not recommended to the FDA;liver failure caution;Pregnant women should not be used. Lactating women with caution. 
Pediatric Use:There is no pediatric experience. 
Geriatric medicine:Reduction or compliance. 
Drug interactions :It is not clear. 
Overdosage:Has yet to see the special signs and symptoms of drug overdose. In case of overdose, to care for patients, treated with conventional supportive therapy. 
Pharmacological effects:This product can reduce the hepatitis B virus (DHBV) infected duck serum DHBV-DNA level; of CCl4 and D-galactosamine-induced toxic liver injury in mice has a protective effect. 
Storage:Shading, closed in a cool place. 
Packing:Infusion bottles. 100ml / bottle, 40 bottles / box.